Genomic Tests Firm Exagen Buying Cypress’ Dx Biz

Exagen will pay Cypress up to $8 million in upfront and milestone payments as well as additional royalty payments for the business.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.